Live Breaking News & Updates on Vikramm Narayan

Stay updated with breaking news from Vikramm narayan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Narayan Discusses Bladder Preservation and the Role of Gene Therapies in NMIBC

Vikram M. Narayan, MD, highlights takeaways from 5-year follow-up data examining the gene therapy nadofaragene firadenovec and details promising emerging therapies for bladder cancer.
....

Emory University Hospital , United States , Emory University , Grady Memorial Hospital , Vikramm Narayan , Winship Cancer Institute In Atlanta , American Urological Association , Urological Association , Annual Meeting , Emory University School , Winship Cancer Institute ,

Dr Narayan on Long-Term Results With Nadofaragene Firadenovec in NMIBC

Dr Narayan on Long-Term Results With Nadofaragene Firadenovec in NMIBC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Vikramm Narayan , Winship Cancer Institute , Department Of Urology , Emory University School Of Medicine , Emory University School , Urologic Oncology , Grady Memorial Hospital ,

Nadofaragene Firadenovec Sets the Stage for Gene Therapies in NMIBC

Nadofaragene Firadenovec Sets the Stage for Gene Therapies in NMIBC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Grady Memorial Hospital , United States , Emory University , Emory University Hospital , Vikramm Narayan , Nadofaragene Firadenovec , American Urological Association , Winship Cancer Institute In Atlanta , Cg Oncology Inc , Ferring Pharmaceuticals , Emory University School , Winship Cancer Institute , Data With Nadofaragene , Novel Therapies Are Under Evaluation , Clinical Oncology Genitourinary Cancers Symposium , Bacillus Calmette Gu , Accessed April ,

Adstiladrin Leads to Beneficial Outcomes in Some Bladder Cancers

Urinary minimal residual disease-negative status was related to preventing the return of cancer when certain patients with bladder cancer received Adstiladrin. ....

United States , Vikramm Narayan , Emory University School Of Medicine , Ferring Pharmaceuticals , Emory University School , Bladder Cancer , Asco Gu24 ,

Urinary MRD Status Potentially Predictive of Recurrence in BCG-Unresponsive NMIBC

Assessment of urinary MRD status identified and enabled quantification of molecular responses with nadofaragene firadenovec in BCG-unresponsive NMIBC. ....

United States , Vikramm Narayan , Intravesical Administration , Ferring Pharmaceuticals , Urology At Emory University School Of Medicine , Emory University School , Clin Oncol , Medicine Clinical Trials , Patients With , Relapsed Bladder , Bladder Cancer , Bacillus Calmette Guérin Bcg Unresponsive , High Grade , Non Muscle Invasive Bladder Cancer , Hase 2 Trial Nct01687244 , Mrd Status , Minimal Residual Disease ,